Inhibition of norepinephrine re-uptake by angiotensin in brain.
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D002552:Cerebral Ventricles / Q000187:drug effects* / Q000378:metabolism*; D003042:Cocaine / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D004357:Drug Synergism; D004558:Electric Stimulation; D005260:Female; D008333:Mandelic Acids / Q000037:antagonists & inhibitors / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism*; D009647:Normetanephrine / Q000378:metabolism; D010477:Perfusion; D010643:Phenoxybenzamine / Q000494:pharmacology; D051381:Rats; D014316:Tritium; D014630:Vagus Nerve / Q000502:physiology
D008333:Mandelic Acids; D009647:Normetanephrine; D010643:Phenoxybenzamine; D014316:Tritium; D000804:Angiotensin II; D003042:Cocaine; D003891:Desipramine; D009638:Norepinephrine